Metastatic Sarcomatoid Renal Cell Carcinoma: Clinical Trials

3 trials for Metastatic Sarcomatoid Renal Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Withdrawn 1
Phase 11Recruiting 1

Follow Metastatic Sarcomatoid Renal Cell Carcinoma: new trials by email Literature Review of Metastatic Sarcomatoid Renal Cell Carcinoma trials Research Report on Metastatic Sarcomatoid Renal Cell Carcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma
Phase 2WithdrawnCity of Hope Medical Center2026-08-112026-10-01
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
Biopsy, Biospecimen Collection, Computed Tomography - Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Sarcomatoid Renal Cell Carcinoma
Phase 1 / Phase 2RecruitingUniversity of Michigan Rogel Cancer Center552025-08-152026-07-31
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Biospecimen Collection, Bone Scan, Cabozantinib S-malate - Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma
Phase 2RecruitingNational Cancer Institute (NCI)3142019-05-132026-10-30

Narrower conditions

Carcinoma, Renal Cell (3)  ·  Clear-cell metastatic renal cell carcinoma (2)  ·  Carcinoma, Transitional Cell (1)  ·  Penile Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Urachal adenocarcinoma (1)  ·  Urethral Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Kidney Neoplasms (3)  ·  Male Urogenital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Urologic Neoplasms (3)  ·  Urogenital Neoplasms (2)

Interventions

Specimen Handling (3)  ·  Biopsy (2)  ·  CTLA-4 Antigen (2)  ·  Ipilimumab (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Nivolumab (2)  ·  Inulin (1)  ·  cabozantinib (1)  ·  tivozanib (1)

Sponsors

City of Hope Medical Center (1)  ·  National Cancer Institute (NCI) (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (3)  ·  Puerto Rico (1)

Top investigators

Andrea B Apolo (1)  ·  Charles B Nguyen (1)  ·  Ulka N Vaishampayan (1)

Results publications

PMID 35031545

NIH funding

P30CA033572 (1), U10CA180821 (1)